Exempting information in collaborative drug therapy agreements from disclosure under the public records act.
HB 2176 exempts collaborative drug therapy agreements from public records disclosure, shielding pharmacist-physician protocols from transparency requirements but potentially limiting oversight of publicly-funded healthcare arrangements.